Faron Pharmaceuticals Oy

Faron Pharmaceuticals Oy (FARN)

Buy
Sell
Company name:Faron Pharmaceuticals Oy
EPIC:FARNTrading Currency:GBX
Market Sector:AMQ1ISIN:FI4000153309
Market Segment:ASQ1Share Type:DE
WWW Address:http://www.faronpharmaceuticals.com/Description:ORD NPV (DI)
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 277.50 images.advfn.com/imagesnew/2/gb/down -2.5 [-0.89] 270.00 285.00 280.00 280.00 267.50 80,196
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 129.91 46.81 0.10 -28.04 - - - 560.00 - 142.50

Faron Pharmaceuticals Oy Key Figures

(at previous day's close)
Market Cap.129.91m
Shares In Issue46.81m
Prev. Close280.00
PE Ratio- 
Dividend Yield-%
EPS - basic-28.04p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-20.83p
Return On Equity (ROE)-823.73%
Operating Margin-%
PEG Factor- 
EPS Growth Rate52.31%
Dividends PS Growth Rate-%
Net Debt1.30m
Gross Gearing84.23%
Quick Assets7.85m
Net Working Capital2.71m
Intangibles / Fixed Assets98.60%
Turnover PS-p
Pre-Tax Profit PS-23.95p
Retained Profit PS-23.97p
Cash PS12.76p
Net Cash PS1.78p
Net Tangible Asset Value PS *1.26p
Net Asset Value PS2.91p
Spread15.00 (5.26%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Faron Pharmaceuticals Oy Balance Sheet

LSE:FARN:Liabilities+EQLSE:FARN:Assets

Share Price Performance

Sample Period †HighLow
1 week320.00267.50
4 weeks451.00267.50
12 weeks520.00267.50
1 year560.00142.50

Share Price Chart (5 years)

Faron Pharmaceuticals Oy Historic Returns

Period †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week317.50-40.00-12.60267.500.05304.08
4 weeks400.00-122.50-30.63267.500.04351.12
12 weeks435.00-157.50-36.21267.500.05411.76
26 weeks372.50-95.00-25.50267.500.06383.10
1 year144.00133.5092.71142.500.12296.78
3 years835.00-557.50-66.7751.000.16161.59
5 years282.50-5.00-1.7751.000.12174.82
† periods calculated are whole weeks rather than calendar months

Faron Pharmaceuticals Oy Key Management Ratios

Faron Pharmaceuticals Oy Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 14.27 
Tobin's Q Ratio (excl. intangibles)15.49 
Dividend Yield-%
Market-to-Book Ratio95.35 
Price-to-Pre-Tax Profit PS-11.59 
Price-to-Retained Profit PS-11.58 
Price-to-Cash Flow PS-13.32 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS220.89 
Price-to-Cash PS21.75 
Net Working Capital PS5.80 
Price Pct to Working Capital PS47.88%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Faron Pharmaceuticals Oy Financial Ratios

(Leverage Ratios)
Debt Ratio61.05%
Debt-to-Equity Ratio1.57 
Debt-to-Equity Ratio (excl. Intgbl)3.63 
Debt-to-Equity Market Value0.02 
Net Gearing15.08%
Net Gearing (excl. Intangibles)16.57%
Gross Gearing84.23%
Gross Gearing (excl. Intangibles)92.52%
Gearing Under 1 Year59.51%
Gearing Under 1 Year (excl. Intgbl)65.36%
Assets/Equity6.34 
Cash/Equity438.45 
(Liquidity Ratios)
Net Working Capital to Total Assets31.40%
Current Ratio1.53 
Quick Ratio (Acid Test)1.53 
Liquidity Ratio1.16 
Cash & Equiv/Current Assets76.06%
(Solvency Ratios)
Enterprise Value126.07m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-1.13 
CFO/Debt-1.34 
Total Debt/Equity Market Value0.06 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.65 
Total Debt7.28m
Total Debt/Net Current Assets2.68%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-25.84%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta (60-Mnth)Beta (36-Mnth)
0.1029-0.0692

Faron Pharmaceuticals Oy Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-320.54%
Return On Assets (ROA)-123.25%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-823.73%
Return On Investment (ROI)-351.21%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

Faron Pharmaceuticals Oy Dividends

Sorry No Data Available

Faron Pharmaceuticals Oy Fundamentals
 31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)31 Dec 2019 (EUR)
turnover1.15100.00%--0.02---m
pre tax profit-9.22-799.57%-21.06--20.08--13.25-m
attributable profit-9.29-806.07%-21.06--20.09--13.26-m
retained profit-9.29-806.07%-21.06--20.09--13.26-m
eps - basic-39.00 -76.00 -65.00 -31.00 
eps - diluted-39.00 -76.00 -65.00 -31.00 
dividends per share- - - - 

Faron Pharmaceuticals Oy Balance Sheet

 31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)31 Dec 2019 (EUR)
LSE:FARN:Liabilities+EQLSE:FARN:AssetsLSE:FARN:Liabilities+EQLSE:FARN:AssetsLSE:FARN:Liabilities+EQLSE:FARN:AssetsLSE:FARN:Liabilities+EQLSE:FARN:Assets
 31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)31 Dec 2019 (EUR)
ASSETS
fixed assets fixed assets0.020.12%0.020.15%0.020.21%0.010.13%m
intangibles intangibles0.935.40%0.332.18%0.536.56%0.928.96%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks1.458.39%--%--%--%m
debtors debtors3.4019.69%5.2335.13%3.3942.40%2.2221.77%m
cash & securities cash & securities11.4866.40%9.3162.54%4.0750.82%7.0669.14%m
TOTAL17.29100%14.89100%8.00100%10.21100%m
LIABILITIES
creditors - short creditors - short4.3725.28%8.0654.11%5.7571.79%6.0859.51%m
creditors - long creditors - long2.0311.76%2.0914.03%1.8923.58%2.5224.72%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL6.4037.05%10.1468.14%7.6395.38%8.6084.23%m
EQUITY
ord cap, reserves ord cap, reserves10.8862.95%4.7431.86%0.374.62%1.6115.77%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL10.8862.95%4.7431.86%0.374.62%1.6115.77%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Faron Pharmaceuticals Oy Cash Flow Statement

31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)31 Dec 2019 (EUR)
Operating CF-8.45-18.36-20.53-11.52m
Pre-Financing CF-8.54-18.46-20.82-11.62m
Retained CF0.41-1.88-5.282.99m

Faron Pharmaceuticals Oy Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
FARN
Faron Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201029 23:48:01